Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular changes in prostatic cancer.

S R J Bott1, M Arya, I S Shergill

  • 1Prostate Cancer Research Centre, Institute of Urology, University College London, 24 St Nicholas Place, Loughton, Essex IG1O 1BF, UK.

Surgical Oncology
|July 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accelerated MRI-Guided Brachytherapy in Cervical Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Acceptability of an integrated care program to identify patients at risk of advanced chronic liver disease in Australian primary care settings.

Australian journal of primary health·2026
Same author

Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men.

Vaccine·2025
Same author

Radioactive seed localization is a safe and effective tool for breast cancer surgery: an evaluation of over 25,000 cases.

Journal of radiological protection : official journal of the Society for Radiological Protection·2024
Same author

Impact of shield location on staff and caregiver dose rates for I-131 radiopharmaceutical therapy patients.

Journal of radiological protection : official journal of the Society for Radiological Protection·2023
Same author

An investigation of blood, milk, and urine test patterns for the diagnosis of ketosis in dairy cows in early lactation.

Journal of dairy science·2022
Same journal

Comparative safety of postoperative HIPEC with recombinant mutant TNF-α versus paclitaxel for gastric cancer peritoneal metastasis: a randomized controlled trial.

Surgical oncology·2026
Same journal

Early postoperative hospital exposome stress, multisystem recovery trajectories, and long-term oncologic outcomes after curative colorectal cancer surgery.

Surgical oncology·2026
Same journal

Prognostic significance of age in adult primary intestinal diffuse large B-cell lymphoma: Insights from the SEER database.

Surgical oncology·2026
Same journal

Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis of long-term outcomes.

Surgical oncology·2026
Same journal

Associations of latent profiles of resilience and fear of progression with discharge symptoms and postoperative frailty among patients undergoing lung resection: A longitudinal study.

Surgical oncology·2026
Same journal

Plastic surgeon or surgical oncologist: Impact of surgical training background on outcomes in microsurgical head and neck reconstruction.

Surgical oncology·2026
See all related articles

Prostate cancer

Area of Science:

  • Oncology
  • Genetics
  • Cancer Research

Background:

  • Prostate cancer is a prevalent and serious male cancer with variable clinical presentations.
  • Its development involves genetic alterations, but the specific causes and mechanisms remain unclear.
  • Understanding these genetic factors is crucial for improving patient outcomes.

Purpose of the Study:

  • To review key genetic markers associated with prostate cancer.
  • To explore their potential roles in early, metastatic, and hormone-refractory stages.
  • To discuss their future applications in diagnosis, prognosis, and therapy.

Main Methods:

  • Literature review of genetic markers in prostate cancer.
  • Analysis of genetic changes in different stages of the disease.

Related Experiment Videos

  • Discussion of diagnostic, prognostic, and therapeutic implications.

    • Main Results:

    • Identified significant genetic markers across various prostate cancer stages.
    • Highlighted the heterogeneity of prostate cancer based on genetic profiles.
    • Emphasized the potential of genetic markers for personalized medicine.

    Conclusions:

    • Genetic markers hold promise for improved prostate cancer diagnosis and prognosis.
    • Targeted therapies based on genetic profiles may enhance treatment efficacy.
    • Further research is needed to fully elucidate the role of genetics in prostate cancer.